Related Experiment Video

Updated: Jun 12, 2026

Phospholipid Mediator Induced Transformation in Three-Dimensional Cultures
08:02

Phospholipid Mediator Induced Transformation in Three-Dimensional Cultures

Published on: July 27, 2022

Phospholipase C-gamma1 is required for the epidermal growth factor receptor-induced squamous cell carcinoma cell

Zhongjian Xie1, Ying Chen, Er-Yuan Liao

  • 1Endocrine Unit, Veterans Affairs Medical Center, Northern California Institute for Research and Education, University of California, San Francisco, CA 94121, USA. Zhongjian.Xie@gmail.com

Biochemical and Biophysical Research Communications
|June 1, 2010
PubMed

Insights

Phospholipase C-gamma1 (PLC-gamma1) drives squamous cell carcinoma (SCC) cell growth, acting downstream of epidermal growth factor receptor (EGFR). Its function in SCC mitogenesis is independent of its catalytic activity.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Epidermal growth factor receptor (EGFR) signaling is crucial for squamous cell carcinoma (SCC) proliferation.
  • Phospholipase C-gamma1 (PLC-gamma1) is a downstream effector of EGFR, but its specific role in SCC mitogenesis is not well understood.

Purpose of the Study:

  • To investigate the role and necessity of PLC-gamma1 in EGFR-induced SCC cell proliferation.
  • To determine if PLC-gamma1's catalytic activity is essential for its function in SCC mitogenesis.

Main Methods:

  • Quantitative analysis of PLC-gamma1 expression in human SCC biopsies and cell lines versus normal tissues.
  • Utilized small interfering RNA (siRNA) to knockdown PLC-gamma1 expression in SCC cells.
  • Inhibited the catalytic activity of phospholipase C enzymes.
  • Observed cellular responses to epidermal growth factor (EGF) stimulation, including PLC-gamma1 localization.

Main Results:

  • PLC-gamma1 expression is significantly elevated in human SCC tissues and cell lines compared to normal counterparts.
  • EGFR-induced SCC cell proliferation was abrogated by PLC-gamma1 knockdown using siRNA.
  • Inhibition of phospholipase C catalytic activity did not impede EGFR-induced SCC cell proliferation.
  • Upon EGF stimulation, PLC-gamma1 translocated to both the plasma membrane and the nucleus.

Conclusions:

  • PLC-gamma1 is essential for EGFR-mediated SCC cell proliferation.
  • The mitogenic function of PLC-gamma1 in SCC is independent of its enzymatic lipase activity.
  • These findings highlight a non-canonical role for PLC-gamma1 in cancer progression, suggesting potential therapeutic targets beyond its enzymatic function.

More Related Videos

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells08:54

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Amplifying Signals via Second Messengers01:15

Amplifying Signals via Second Messengers

Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...